GEO Investing
If you are a premium member make sure you sign in to see All the exclusive content In This Issue.

This week’s Microcap Information Arbitrage Weekly Wrap-Up is ready — spotlighting key moves, missed signals, and overlooked opportunities in our 1,500+ coverage universe built since 2009.

—

If you enjoy performing press release research or think you will see value in a tool that expedites your press release research process, you should check out a press release tool my team is building by going here. It basically aggregates all microcap press releases in a convenient platform and allows you to search, filter by symbol and keywords, as well as categories. You are now able to create a free account on this application. This is important because it lets you experience the NEW, powerful research capabilities of the tool before it’s officially launched. Create your free account here.

—

Summary Of What’s In This Weekly Wrap-Up

The big news this week was Friday’s morning email, where we reported on a very positive NEW InfoArb development regarding the Tecogen Inc. (NYSE:TGEN) partnership with Vertiv Holdings, Llc (NYSE:VRT). Just like when the original signing of this partnership agreement was initially ignored in March, when TGEN was around $2.50 due to tariff war noise, this positive partnership update seems to be getting little love, as AI and data center stocks have gone out of favor… for a minute.

We also hosted another Skull Session event. Last week, we spoke with Derek Webb, CEO of Biorem, Inc. (OOTC:BIRMF) (TSXV:BRM), ahead of their Q3 earnings report. This week, we reconnected with him to catch up following the release of the earnings report. We focused on the company’s growing recurring revenue vertical, expected to help smooth out quarterly sales performance inherent in other parts of their business. If successful, BIRMF’s valuation multiples could eventually expand. Other highlights in this weekly update include:

Here’s a snapshot of the earnings reports we will be discussing later on in this post:

Flexible Solutions International (NYSE:FSI) reported Q3 results and discussed startup costs and tariff impacts tied to its food-contracts.

Biorem, Inc. (OOTC:BIRMF) (TSXV:BRM) posted lower year-over-year revenue but reached a record backlog supported by international project activity. As I mentioned, as a follow-up to our management briefing last week, we also had a post-earnings conversation with the BIRMF CEO, which we will recap later.

Konatel, Inc. (OTCQB:KTEL) released Q3 results that reflected expected weakness and disclosed that its new healthcare-channel partnership officially went into motion.

Intouch Insight Ltd. (OTC:INXSF) (TSXV:INX) reported an unexciting Q3, but set long-term growth targets, supported by SaaS expansion. At this point, investors are probably going to take a wait and see stance.

Covalon Technologies Ltd. (OTC:CVALF) (TSXV:COV) issued its first-ever special dividend, following a couple years of operational improvement. However, progress has flattened out, and we’re waiting for the next inflection point to occur.

So far in 2025, we’ve highlighted 347 earnings reports, helping premium subscribers with their research. Here’s a table that summarizes all the reports highlighted in our morning emails last week:

Now, let’s take a closer look at each earnings report and update.

—

Earnings and Research Updates

As a reminder, you can see all of our archived morning emails here.

Flexible Solutions International (NYSE:FSI), a specialty chemicals company, reported Q3 revenue of $10.6 million, up from $9.3 million in the same period last year. The company reported a loss per share of ($0.04) versus earnings per share of $0.05. Higher cost of goods, tariffs, and startup expenses tied to a new food-grade contract affected the quarter. Management noted that Q4 results should finally benefit

——

Sorry, the full post is only available for paying subscribers. If you are already a paying subscriber, please make sure you are logged in. To become a paying subscriber please click on the link below
(We also offer a new very popular monthly subscription option).
gain Exposure to our expanded coverage on Our 1500+ Microcap Universe, Subscribe below.

200+ multibaggers and counting



GeoInvesting is a premier research platform for microcap investors, dedicated to uncovering high-potential stock ideas in undervalued companies across various sectors. With over 30 years of investing experience, GeoInvesting has covered more than 1,500 equities, providing often actionable proprietary research. The platform has been instrumental in identifying 200+ multibagger stocks, and offers investors exclusive access to over 600 management interview clips, allowing for deeper due diligence and understanding of the microcap stocks, many of which make it to market-beating premium Model Portfolios. Join the GeoInvesting community for the best stock research and microcap insights to help you stay ahead in the market. To learn more about our Premium Services, go here.. (https://geoinvesting.com/premium-research/)

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.